US at a glance
- Population
- 341.8 million 2025
- Life expectancy at birth
- 78.9 years, 2024
- People aged 65 and over
- 18.4 % of people, 2025
- Health spending per person
- 13,473 US$ per person, 2023
- Doctors
- 3.68 per 1,000 people, 2022
Updated
Reviewed by Vidhi Upadhyay
US Home Oxygen Therapy Market Industry Trends and Forecast to 2034: Segmented by (Product, Indication, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$1.05 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.81 Bn | — | — |
| 2025 (base) | $1.90 Bn | +$90.4 Mn | — |
| 2026 (forecast) | $1.99 Bn | +$95.0 Mn | +5% |
| 2027 (forecast) | $2.09 Bn | +$99.7 Mn | +10.3% |
| 2028 (forecast) | $2.20 Bn | +$104.7 Mn | +15.8% |
| 2029 (forecast) | $2.31 Bn | +$109.9 Mn | +21.6% |
| 2030 (forecast) | $2.42 Bn | +$115.4 Mn | +27.6% |
| 2031 (forecast) | $2.55 Bn | +$121.2 Mn | +34% |
| 2032 (forecast) | $2.67 Bn | +$127.3 Mn | +40.7% |
| 2033 (forecast) | $2.81 Bn | +$133.6 Mn | +47.7% |
| 2034 (forecast) | $2.95 Bn | +$140.3 Mn | +55.1% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $1.90 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $2.95 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 5.0% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, indication and end user (see all) |
| Key players | Inogen, Philips Healthcare, ResMed Inc., Linde, Air Liquide (see all) |
| Regulator in the US | FDASource: US Food and Drug Administration. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Home oxygen therapy supplies extra oxygen at home or on the go for people with long-term lung disease.
Key segments of the home Oxygen Therapy market include product (Oxygen Concentrators, Portable Concentrators and Oxygen Cylinders) and indication (COPD, Pulmonary Fibrosis and Heart Failure).
Rising rates of chronic disease linked to diabetes, ageing, smoking and pollution, plus new treatments that slow disease, are driving the home Oxygen Therapy market.
Earlier screening, new drug classes and home-based care give the home Oxygen Therapy market room to grow.
Late diagnosis, high prices of new medicines, limited specialist care and poor adherence hold back the home Oxygen Therapy market.
The home Oxygen Therapy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
The FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA).[1] Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).[2]
[1] US Food and Drug Administration. Checked 14 Nov 2026.
[2] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how home Oxygen Therapy products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.
What doctors and scientists are doing in Home Oxygen Therapy right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.
From our blog
US · 1 shared keyword
US · 1 shared keyword
US
US
US
US
Healthcare Services · US
Digital Health · US
Pharmaceuticals · US
Digital Health · US
Pharmaceuticals · US
Pharmaceuticals · US